The overall goal of this project is to characterize the effects of tetracyclines on osteoclast and osteoblast function in vitro. Preliminary data indicate that tetracyclines inhibit osteoclastic activity while stimulating osteoblastic function. The inhibitory effects of tetracyclines will be examined by studying key aspects of osteoclastic function: a) osteoclast ruffled border development will be evaluated using cultured fetal rat long bones and morphometric techniques; b) resorption of devitalized bone by isolated osteoclasts will be assessed with disaggregated rat osteoclasts cultured on devitalized bone and an enriched preparation of avian osteoclasts cultured on prelabeled bone chips; c) acidification mechanism of osteoclasts will be assessed with acridine orange fluorescence in whole cells and in plasma membranes; d) activities of osteoclastic lysosomal cysteine proteinases will be accomplished by spectrofluorometric assay of cathepsin B and L; e) osteoclast cytosolic free calcium will be examined by single cell measurements of cytosolic calcium using Fura-2; f) osteoclast podosome formation will be assessed in chicken osteoclasts by rhodamine-labelled phalloidin and, g)) osteoclast oxygen radical production will be examined in stimulated avian osteoclasts by established spectrophotometric assays. The anabolic effects of tetracyclines will be evaluated using isolated rodent periosteal and endosteal osteoprogenitor cells and osteoblasts. The studies will include tetracyclines effects on a) parameters of osteoblastic function such as proliferation, collagen synthesis, collagen types, collagenase production, alkaline phosphatase action, proteoglycan synthesis, osteocalcin production, bone nodule formation, and interaction with known immune and bone regulatory factors; and b) to determine the mechanism of action of tetracycline on eliciting a biological effect by using second messenger assays. Furthermore, molecular biological technology will be used to determine whether the effects of tetracyclines are mediated through translation or transcription control. Results from these studies should provide a rational basis for an understanding of the effects of tetracycline in vivo and their potential therapeutic value in the management of bone destructive disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
1R01DE009576-01
Application #
3223362
Study Section
Oral Biology and Medicine Subcommittee 1 (OBM)
Project Start
1990-07-01
Project End
1993-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost
Name
New York University
Department
Type
Schools of Dentistry
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Ramamurthy, Nungavarum S; Rifkin, Barry R; Greenwald, Robert A et al. (2002) Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines. J Periodontol 73:726-34
Llavaneras, A; Golub, L M; Rifkin, B R et al. (1999) CMT-8/clodronate combination therapy synergistically inhibits alveolar bone loss in LPS-induced periodontitis. Ann N Y Acad Sci 878:671-4
Sorsa, T; Ramamurthy, N S; Vernillo, A T et al. (1998) Functional sites of chemically modified tetracyclines: inhibition of the oxidative activation of human neutrophil and chicken osteoclast pro-matrix metalloproteinases. J Rheumatol 25:975-82
Vernillo, A T; Rifkin, B R (1998) Effects of tetracyclines on bone metabolism. Adv Dent Res 12:56-62
Zaidi, M; Shankar, V S; Adebanjo, O A et al. (1996) Regulation of extracellular calcium sensing in rat osteoclasts by femtomolar calcitonin concentrations. Am J Physiol 271:F637-44
Debari, K; Sasaki, T; Udagawa, N et al. (1995) An ultrastructural evaluation of the effects of cysteine-proteinase inhibitors on osteoclastic resorptive functions. Calcif Tissue Int 56:566-70
Zaidi, M; Shankar, V S; Tunwell, R et al. (1995) A ryanodine receptor-like molecule expressed in the osteoclast plasma membrane functions in extracellular Ca2+ sensing. J Clin Invest 96:1582-90
Kremer, M; Judd, J; Rifkin, B et al. (1995) Estrogen modulation of osteoclast lysosomal enzyme secretion. J Cell Biochem 57:271-9
Ramamurthy, N; Greenwald, R; Moak, S et al. (1994) CMT/Tenidap treatment inhibits temporomandibular joint destruction in adjuvant arthritic rats. Ann N Y Acad Sci 732:427-30
Vernillo, A T; Ramamurthy, N S; Golub, L M et al. (1994) The nonantimicrobial properties of tetracycline for the treatment of periodontal disease. Curr Opin Periodontol :111-8

Showing the most recent 10 out of 21 publications